Douglas Jermasek serves as Executive at Unicycive Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Douglas Jermasek has executed 1 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Jul 11, 2023 involved exercising options for 104,612 shares valued at $0.
| DATE | TICKER | VALUE | TYPE | SHARES | PRICE | 10b5-1 |
|---|---|---|---|---|---|---|
| Jul 11, 2023 | UNCY | $0 | Option Exercise | 104,612 | $N/A | Discretionary |
Douglas Jermasek currently holds 175,012 shares of Unicycive Therapeutics, Inc. (UNCY), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Douglas Jermasek has been a net neutral trader of UNCY stock. They have purchased $0 and sold $0 worth of shares.
Douglas Jermasek's most recent insider trade was on Jul 11, 2023, when they sold 104,612 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted